Cardiovascular diseases
Conditions
Interventions
None listed
Sponsors
Kobe University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients whose fecal LPS were measured in previous studies.
Exclusion criteria
Exclusion criteria: Patients who do not agree to participate the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The gut microbiota which contribute to fecal LPS levels. | — |
Countries
Japan
Contacts
Public ContactTomoya Yamashita
Kobe University Graduate School of Medicine Division of Cardiovascular Medicine, Department of Internal Medicine
Outcome results
None listed